Literature DB >> 24896319

Multivariate equivalence tests for use in pharmaceutical development.

Thomas Hoffelder1, Rüdiger Gössl, Stefan Wellek.   

Abstract

Statistical equivalence analyses are well-established parts of many studies in the biomedical sciences. Also in pharmaceutical development and manufacturing equivalence testing methods are required in order to statistically establish similarities between machines, process components, or complete processes. This article presents a choice of multivariate equivalence testing procedures for normally distributed data as generalizations of existing univariate methods. In all derived methods, variability is interpreted as nuisance parameter. The use of the proposed methods in pharmaceutical development is demonstrated with a comparative analysis of dissolution profiles.

Keywords:  Delta method; Dissolution profiles; Mahalanobis distance; Multivariate equivalence testing; Principle intersection–union; Similarity factor; Two-sample design

Mesh:

Substances:

Year:  2015        PMID: 24896319     DOI: 10.1080/10543406.2014.920344

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Acute cognitive impairment after traumatic brain injury predicts the occurrence of brain atrophy patterns similar to those observed in Alzheimer's disease.

Authors:  Kenneth A Rostowsky; Andrei Irimia
Journal:  Geroscience       Date:  2021-04-26       Impact factor: 7.713

2.  DISSOLUTION PROFILE SIMILARITY ANALYSES-STATISTICAL PRINCIPLES, METHODS AND CONSIDERATIONS.

Authors:  Thomas Hoffelder; David Leblond; Leslie Van Alstine; Dorys Argelia Diaz; Sandra Suarez-Sharp; Krista Witkowski; Stan Altan; James Reynolds; Zachary Bergeron; Kevin Lief; Yanbing Zheng; Andreas Abend
Journal:  AAPS J       Date:  2022-04-06       Impact factor: 4.009

3.  Acute cognitive deficits after traumatic brain injury predict Alzheimer's disease-like degradation of the human default mode network.

Authors:  Andrei Irimia; Alexander S Maher; Nikhil N Chaudhari; Nahian F Chowdhury; Elliot B Jacobs
Journal:  Geroscience       Date:  2020-08-02       Impact factor: 7.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.